11:30 AM SIGN-IN & LUNCH • 12:00 PM - 1:30 PM
BANDOL 1 (NEW WYNN SPACE)
CE: Influenza Treatment: Exploring the Clinical and Economic Benefits of Antivirals
Despite the worldwide concern of influenza every season, the burden remains high, with an estimated 36 million individuals having symptomatic illnesses in the United States in the 2018-2019 season. Antivirals are important in not just decreasing symptoms associated with influenza, but also in reducing complications that may require additional treatment or hospitalization. It is imperative that pharmacists are able to identify individuals who are at high risk of serious influenza-related complications and understand the nuances of the 4 approved antivirals recommended by the CDC this season: baloxavir, oseltamivir, peramivir, and zanamivir. Improving clinical and economic outcomes necessitates an understanding of appropriate diagnostic testing to initiate antiviral therapy, improving timing of antiviral therapy, and assisting with patient access.